PRESS RELEASE published on 02/08/2024 at 22:05, 2 years 4 months ago Applied DNA Announces First Quarter Fiscal Year 2024 Financial Results Applied DNA Sciences, Inc. (NASDAQ:APDN) announces Q1 fiscal year 2024 financial results and progress on GMP production capacity for mRNA therapeutics. Projects initial facility capacity to enable up to $15 million Linea IVT revenue annually Financial Results Applied DNA Sciences MRNA Therapeutics GMP Production Capacity Linea IVT Revenue
PRESS RELEASE published on 02/05/2024 at 19:00, 2 years 4 months ago Applied DNA to Report First Quarter Fiscal 2024 Financial Results on Thursday, February 8, 2024 Applied DNA Sciences, Inc. will release first quarter fiscal 2024 financial results after market close on February 8, 2024, with a conference call for analysts. The company operates in biotechnology developing DNA detection and production technologies Financial Results Conference Call Biotechnology Applied DNA Sciences DNA Detection
PRESS RELEASE published on 02/02/2024 at 22:15, 2 years 4 months ago Applied DNA Announces Closing of $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Applied DNA Sciences, Inc. closes registered direct offering of common stock priced at-the-market with institutional investors. Proceeds to be used for therapeutic DNA production services Registered Direct Offering Institutional Investors Common Stock Applied DNA Sciences DNA Technologies
PRESS RELEASE published on 01/31/2024 at 14:00, 2 years 4 months ago Applied DNA Announces $3.44 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules Applied DNA Sciences, Inc. announces a registered direct offering and a concurrent private placement to certain existing institutional investors. Maxim Group LLC acts as exclusive placement agent Registered Direct Offering Applied DNA Sciences Securities Purchase Agreements Maxim Group LLC DNA Technologies
PRESS RELEASE published on 12/14/2023 at 14:00, 2 years 6 months ago Applied DNA Announces Joint Development Agreement to Integrate Linea(TM) IVT Platform into CDMO Kudo Biotechnology’s mRNA Manufacturing Workflow
PRESS RELEASE published on 12/07/2023 at 22:05, 2 years 6 months ago Applied DNA Announces Fourth Quarter Fiscal Year 2023 Financial Results
PRESS RELEASE published on 12/05/2023 at 14:30, 2 years 6 months ago Applied DNA to Report Fiscal 2023 Fourth Quarter and Year End Financial Results on December 7, 2023 Applied DNA Sciences, Inc. (NASDAQ:APDN) will release its Q4 and full year 2023 financial results on December 7, 2023, after the market close. A conference call for investors will follow to discuss the results Financial Results Conference Call Investor Relations Applied DNA Sciences NASDAQ:APDN
PRESS RELEASE published on 11/28/2023 at 14:30, 2 years 6 months ago Applied DNA Announces Receipt of Linea(TM) DNA Follow-On Order for Cancer Diagnostic Application
PRESS RELEASE published on 11/16/2023 at 14:30, 2 years 7 months ago Applied DNA Extends Application of Linea(TM) IVT Platform to saRNA (self-amplifying mRNA)
PRESS RELEASE published on 11/09/2023 at 15:15, 2 years 7 months ago Applied DNA Ships First saRNA (self-amplifying mRNA) IVT Template Generated by Linea(TM) DNA Platform
Published on 06/18/2026 at 00:00, 5 hours 43 minutes ago LIR Life Sciences Completes Comparative Animal Study Showing Successful Protamine-Enhanced Permeation Transport of Both Semaglutide and Tirzepatide
Published on 06/17/2026 at 23:30, 6 hours 13 minutes ago Polaris Renewable Energy Announces Postponement of Annual Meeting of Shareholders
Published on 06/17/2026 at 22:50, 6 hours 53 minutes ago International Battery Metals Ltd. Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results
Published on 06/17/2026 at 22:30, 7 hours 13 minutes ago Innodata Appoints Jayant Chauhan as Chief Financial Officer
Published on 06/17/2026 at 16:55, 12 hours 48 minutes ago Snipp Interactive Named a Representative Vendor in the Gartner(R) 2026 Market Guide for Loyalty Program Vendors
Published on 06/18/2026 at 04:05, 1 hour 37 minutes ago Hisense Brings Smarter Home Experiences to Families During the FIFA World Cup 2026™
Published on 06/18/2026 at 02:45, 2 hours 57 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Update on APAC matter
Published on 06/17/2026 at 21:40, 8 hours 2 minutes ago Tinnitus Quest Builds Momentum with Oxford Research Study, New Funding Call, and Second Tinnitus Hackathon
Published on 06/17/2026 at 19:10, 10 hours 32 minutes ago Africa Finance Corporation and Leading Italian Institutions Sign Strategic Cooperation Agreements at AFC-Italy Forum to Mobilise Capital and Accelerate Industrial Development Across Africa
Published on 06/17/2026 at 18:40, 11 hours 2 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 06/17/2026 at 17:40, 12 hours 3 minutes ago Report on share repurchases from 10 to 16 June 2026
Published on 06/17/2026 at 08:45, 20 hours 58 minutes ago Air Liquide is awarded its largest-ever contract in Spain to care for 90,000 patients living with respiratory conditions at home
Published on 06/16/2026 at 11:44, 1 day 17 hours ago Guillemot Corporation S.A. | Weekly report share buyback from June 8 to June 12 2026
Published on 06/15/2026 at 23:00, 2 days 6 hours ago BIOPHYTIS ANNOUNCES THE TEMPORARY SUSPENSION OF THE TRADING OF ITS SHARES
Published on 06/15/2026 at 18:57, 2 days 10 hours ago Reporting on share buyback transactions carried out between June 8 and June 11, 2026